This strategic assessment of Bayer, one of the world's leading agrochemical companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The new report from VPGMarketResearch.com presents a comprehensive analysis of the company's performance, capabilities, goals and strategies in the global agrochemical market.
SECTION I: EXECUTIVE SUMMARY
A 3-5 page synopsis of key sections.
SECTION II: BUSINESS ORGANIZATION
History of the companys agrochemical business evolution, which is important to understanding
the corporate culture, management mentality and strategies.
Recent acquisitions, divestitures and major organizational changes.
Current organizational structure.
SECTION III: SENIOR MANAGEMENT
Names, titles and background of key executives.
SECTION IV: FACILITIES AND EMPLOYEES
Administrative, manufacturing and R&D facilities in the U.S. and abroad.
New plants under construction.
The U.S. and international work force size and distribution.
SECTION V: TECHNOLOGICAL KNOW-HOW
Internally developed and acquired agrochemical and related capabilities.
Proprietary technologies and patent litigation.
SECTION VI: PRODUCT PORTFOLIO
Review of major product lines.
Applications, advantages and weaknesses of leading products.
SECTION VII: MARKETING TACTICS
Product service and support.
SECTION VIII: FINANCIAL ANALYSIS
Estimated sales by division, geographic region and product line. .
Five-year sales and operating profit performance.
SECTION IX: R&D EXPENDITURES AND MAJOR PROGRAMS
Estimated R&D budget.
Research facilities and staff.
New technologies, products and applications in development.
SECTION X: COLLABORATIVE ARRANGEMENTS
Joint ventures, distribution, O.E.M. and licensing partners, both industrial and academic.
Terms of collaborative agreements and specific products involved.
SECTION XI: STRATEGIC DIRECTION
Specific business, new product development and marketing strategies.
Anticipated acquisitions, joint ventures and divestitures.
Contains66 pages and 17 tables
SIMILAR MARKET STUDIES
This report provides an overview of the UK blood banking market, including sales and market shares of leading suppliers of blood typing, grouping and infectious disease screening tests, as well as test volume and sales forecasts by market segment.
February 2014 | $0 | View Details >>
Notes: Production, means the output of 3,3?,5,5?-Tetramethylbenzidine?TMB? Revenue, means the sales value of 3,3?,5,5?-Tetramethylbenzidine?TMB? This report studies 3,3?,5,5?-Tetramethylbenzidine?TMB? in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with capacity, production, price, revenue and market share for each manufacturer, covering ...
September 2016 | $2900 | View Details >>
Complete report $6,700. DataPack (test volumes, sales forecasts, supplier shares) $4,300. “2015-2019 France Virology and Bacteriology Testing Market” is a new strategic analysis of major business opportunities emerging in the infectious disease testing market during the next five years. The report examines key French market trends; reviews current and emerging assays; ...
September 2015 | $4300 | View Details >>
This new 269-page report from Venture Planning Group provides a comprehensive analysis in the Italian endocrine function market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares and strategic profiles of leading suppliers.
December 2013 | $1500 | View Details >>
UPCOMING MARKET RESEARCH REPORTS
2017 © Copyright Big Market Research